30 December 2020 - Deborah Wilkes
Premium
Alliance Pharma has strengthened its consumer healthcare presence in the US by acquiring Biogix, including its Amberen brand, for USD110 million in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.